Search Results
Jan 29, 2026, 10:06 ET Sprout Pharmaceuticals' Addyi® (flibanserin) Named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards
December 2025, the U.S. Food and Drug Administration expanded Addyi's approval from premenopausal women to include women with HSDD under 65 regardless of peri or post-menopausal status. This approval closed a long-standing gap in care and recognized Addyi's well-established safety and efficacy profile backed
More news about: Sprout Pharmaceuticals
Jan 14, 2026, 05:28 ET Park Medi World Steps Up National Expansion, Targets 5,000+ Beds by FY28
multi-super-specialty facility enhances access to advanced tertiary care in an underpenetrated market. In Delhi NCR, expansion across dense urban and peri-urban catchments improves revenue density and scale in a competitive corridor. In Punjab, the move to full ownership of a stabilized hospital enables
More news about: Park Medi World Ltd
Jan 13, 2026, 09:57 ET Adam Milstein to Host Panel on Combating Antisemitism at 10th IAC National Summit
community.Milstein will also participate in a second panel at the summit, "Philanthropy in the Duty of Israel," alongside Dr. Miriam Adelson and Noa Peri-Jensch of the Israeli American Council, scheduled for 11:00 AM to 12:00 PM on Saturday, January 17, 2026.About Adam MilsteinAdam
More news about: Israeli-American Council
Jan 13, 2026, 03:26 ET Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
China.Immunofoco has developed several innovative platforms that overcome the treatment challenges of solid tumors. These platforms, such as Peri Cruiser, SNR, T-Booster, FOCO-CAR, Solid Guard are designed to improve the safety and efficacy of CAR-T products by 1) limiting CART entry to normal
More news about: Immunofoco Biotechnology
Jan 12, 2026, 08:34 ET MediKarma Launches Healthcare's First "Agentic AI" Licensing Model: Opens Access to Validated Disease Management Agents
average – and achieved 40%+ improvement over baseline measures.Women's Health Jill: A specialized agent for IVF, pregnancy and peri/menopause support.Pipeline Agents: Specialized agents for Oncology, Nephrology (CKD) and CHF are currently in development.Quote
More news about: MediKarma Inc.
Jan 09, 2026, 06:30 ET Controlled Environment Agriculture Market to Reach USD 271.01 Billion by 2032 as Climate Volatility and Urban Food Demand Redefine Modern Farming
climate-resilient food productionExpansion of vertical and indoor farmingGreater automation and AI-driven crop managementRising urban and peri-urban demandAccording to DataM Intelligence analysis:Greenhouses will remain the largest facility typeLeafy
More news about: DataM Intelligence 4 Market Research LLP
Jan 08, 2026, 08:00 ET Roland DG Announces Global Distribution Partnership with LSINC, Expanding Access to Industrial Direct-to-Object Printing Worldwide
2026 will have the opportunity to experience live demonstrations and explore the production capabilities of the Peri-series within the LSINC booth (Booth 5577).Subsequently, the LSINC Peri-series will be available globally through Roland DG's network of subsidiaries. To learn more about the LSINC
More news about: Roland DGA
Jan 07, 2026, 10:05 ET Creation Investments Announces Final Close of Impact Credit Fund II
provide responsible access to credit for micro and small businesses, affordable housing, electric vehicles, and smallholder farms and agriculture in peri-urban and rural India. All of Creation Investments' financial inclusion investments have investment-grade credit ratings, underscoring the fund's focus
More news about: Creation Investments Capital Management, LLC
Jan 06, 2026, 10:25 ET Legacy Healthcare to Advance Topical Solution Cinainu into International Phase 3 Trial for Alopecia Areata following US FDA Clearance
botanical drug-candidate with a well-established safety profile and patent protection until 2043. In clinical and preclinical studies, Cinainu restored peri-follicular anti-apoptotic protein Bcl-2 to near-normal levels, increased epidermal Langerhans cells density, reduced endothelial expression of T-cell
More news about: Legacy Healthcare
Dec 18, 2025, 17:20 ET SAG AWARD WINNER PERI GILPIN AND DAUGHTER AVA VINCENT JOIN THE PRODUCING TEAM FOR "JO - THE LITTLE WOMAN MUSICAL"
next!"Peri Gilpin is best-known to television audiences as radio producer "Roz Doyle" in NBC's Emmy-winning comedy series "Frasier." Peri reprised her role in the Paramount+ sequel series. In 2024, she played Elizabeth Moss's mother in Max Minghella's film Shell. In addition, Peri played
More news about: 4 Times Entertainment, Inc.
Dec 18, 2025, 09:00 ET Freda Key C Presents Advanced Recombinant Collagen Delivery Technology at SCC79
brand built around recombinant collagen, Freda is extending this technology from the laboratory and the clinic into daily skincare. Key C focuses on peri-procedural care and anti-aging, using its "Cell-penetrating collagen" concept and delivery technologies to offer evidence-based solutions for consumers
More news about: Shandong Freda Biotech Co., Ltd.
Dec 15, 2025, 12:26 ET Bell Law Firm Secures $48 Million Verdict for Georgia Vietnam Veteran Permanently Disfigured After Doctor Failed to Diagnose and Treat Recurrent Cancer
2013, Dr. Payne removed a skin cancer in front of Mr. Waldrop's right ear. Pathology revealed the tumor surrounded nerve cells, a condition known as "peri-neural invasion." PNI is a high-risk feature that indicates the cancer is aggressive and more likely to recur."For patients like Tony who have a
More news about: Bell Law Firm
Dec 08, 2025, 09:05 ET CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT
patients with a history of asthma or other allergic type reactions after taking aspirin or other NSAIDs. Caldolor is contraindicated for use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery. For full prescribing and safety information, including boxed warning,
More news about: Cumberland Pharmaceuticals Inc.
Dec 04, 2025, 13:31 ET University of Utah Education Researchers Awarded $8 million for the Prison Education Action Research Lab (PEARL)
Prison Education Research Initiative (PERI), is a first-of-its-kind multi-institutional study that will address urgent policy- and practice-relevant research questions.Led by Castro and co-PI Jason Taylor, associate professor of educational leadership and policy, PERI will collect systematic and longitudinal
More news about: The University of Utah
Dec 04, 2025, 07:08 ET Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development
pelvic pain score reduced by 52%Most patients maintained normal menstrual cyclesNo typical peri-menopausal symptoms were reported in patientsNo significant changes in bone mineral density or sex hormone levels
More news about: Hope Medicine
Nov 24, 2025, 10:45 ET Cosmetic Dentistry Market is expected to generate a revenue of USD 42.79 Billion by 2032, Globally, at 6.47% CAGR: Verified Market Research®
(Soft Tissue Lasers, Hard Tissue Lasers), By Application (Conservative Dentistry, Endodontic Treatment, Periodontics, Oral Surgery, Implantology, Peri-implantitis, Tooth Whitening), By End-User (Dental Clinics, Hospitals, Academic & Research Institutes, Ambulatory Surgical Centers), By Geographic Scope,
More news about: Verified Market Research
Nov 21, 2025, 14:00 ET Monument Chemical Appoints Sarves Peri as New President
2025 /PRNewswire/ -- Monument Chemical, a global producer of specialty chemicals, announced today that Sarves Peri has been appointed President of Monument Chemical, effective January 1, 2026. Peri will succeed current President Paul Raymond, who will retire in July 2026 after leading the company through
More news about: Monument Chemical
Nov 15, 2025, 10:00 ET Zavation Medical Products Announces First Implantations of Varisync® ALIF NanoPrime™
Dentistry, University of Mississippi Medical Center, 2024. Olivares-Navarrete, R., et al. "Implant Materials Generate Different Peri-implant Inflammatory Factors: PEEK Promotes Fibrosis and Microtextured Ti Promotes Osteogenic Factors." Spine, vol. 40, no. 6; 2015, pp. 399–404.
More news about: Zavation Medical Products, LLC.
Nov 14, 2025, 12:21 ET Zavation Medical Products Announces NanoPrime™: A Breakthrough in PEEK and Titanium Hybrid Interbodies
Dentistry, University of Mississippi Medical Center, 2024. Olivares-Navarrete, R., et al. "Implant Materials Generate Different Peri-implant Inflammatory Factors: PEEK Promotes Fibrosis and Microtextured Ti Promotes Osteogenic Factors." Spine, vol. 40, no. 6; 2015, pp. 399–404.
More news about: Zavation Medical Products, LLC.
Nov 11, 2025, 11:00 ET INTRODUCING PERI: THE FIRST WEARABLE THAT DETECTS AND DECODES THE SYMPTOMS OF PERIMENOPAUSE
Peri, the world's first wearable designed to detect and decode symptoms of perimenopause. A 2025 CES Innovation Awards Honoree in Digital Health, Peri is now available for U.S. pre-order ahead of its December launch, bringing
More news about: IdentifyHer
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
18.2% body weight, while peri-menopausal women lost 15%, and post-menopausal women lost an average of 15.7% body weight over 64 weeks. The percentage of women in the analysis who achieved more than 15% weight loss included: 58.1% (in the pre-menopausal group), 56.5% (in the peri-menopausal group), and
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
18.2% body weight, while peri-menopausal women lost 15%, and post-menopausal women lost an average of 15.7% body weight over 64 weeks. The percentage of women in the analysis who achieved more than 15% weight loss included: 58.1% (in the pre-menopausal group), 56.5% (in the peri-menopausal group), and
More news about: NOVO NORDISK INC.
Nov 04, 2025, 17:00 ET CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
patients with a history of asthma or other allergic type reactions after taking aspirin or other NSAIDs. Caldolor is contraindicated for use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery. For full prescribing and safety information, including boxed warning,
More news about: Cumberland Pharmaceuticals Inc.
Oct 30, 2025, 08:30 ET Biomarker-Driven Therapy Launch Strategies for Global Success, Upcoming Webinar Hosted by Xtalks
therapy with global access and diagnostic success. Join Gudrun Baenfer, PhD, Client Relations and Business Expansion Manager, Peri and Post Approval Services,
More news about: Xtalks
Oct 23, 2025, 17:31 ET Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight
HRO761 (Novartis), a first-in-class WRN helicase inhibitor matched to MSI-H/dMMR tumors. As MSI testing penetration grows and multiple first-line and peri-operative studies report outcomes, revenue is expected to remain robust despite PD-1 class crowding. Key differentiators will be earlier-line use, combination
More news about: DelveInsight Business Research, LLP